Parametric Portfolio Associates LLC raised its stake in shares of Aceto Corporation (NASDAQ:ACET) by 24.7% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 30,999 shares of the company’s stock after buying an additional 6,140 shares during the quarter. Parametric Portfolio Associates LLC owned about 0.10% of Aceto worth $479,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently made changes to their positions in ACET. Northern Trust Corp boosted its position in shares of Aceto by 18.2% during the 2nd quarter. Northern Trust Corp now owns 1,556,429 shares of the company’s stock valued at $24,047,000 after acquiring an additional 239,212 shares during the last quarter. Vanguard Group Inc. boosted its position in shares of Aceto by 14.1% during the 2nd quarter. Vanguard Group Inc. now owns 1,545,990 shares of the company’s stock valued at $23,887,000 after acquiring an additional 191,584 shares during the last quarter. Deprince Race & Zollo Inc. boosted its position in shares of Aceto by 2.7% during the 2nd quarter. Deprince Race & Zollo Inc. now owns 1,288,994 shares of the company’s stock valued at $19,915,000 after acquiring an additional 34,447 shares during the last quarter. Denver Investment Advisors LLC boosted its position in shares of Aceto by 1.3% during the 2nd quarter. Denver Investment Advisors LLC now owns 887,443 shares of the company’s stock valued at $13,711,000 after acquiring an additional 11,512 shares during the last quarter. Finally, King Luther Capital Management Corp boosted its position in shares of Aceto by 35.6% during the 2nd quarter. King Luther Capital Management Corp now owns 572,826 shares of the company’s stock valued at $8,850,000 after acquiring an additional 150,500 shares during the last quarter. 78.81% of the stock is owned by institutional investors and hedge funds.

Shares of Aceto Corporation (ACET) opened at $10.19 on Friday. The stock has a market capitalization of $306.81, a price-to-earnings ratio of 8.49, a P/E/G ratio of 0.95 and a beta of 1.38. Aceto Corporation has a 52-week low of $8.29 and a 52-week high of $22.46. The company has a debt-to-equity ratio of 0.77, a current ratio of 2.06 and a quick ratio of 1.46.

Aceto (NASDAQ:ACET) last issued its quarterly earnings results on Thursday, November 2nd. The company reported $0.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.28 by $0.02. The company had revenue of $185.26 million during the quarter, compared to the consensus estimate of $190.58 million. Aceto had a return on equity of 10.18% and a net margin of 1.07%. Aceto’s revenue was up 44.7% on a year-over-year basis. During the same period last year, the company earned $0.28 earnings per share. analysts anticipate that Aceto Corporation will post 1.07 EPS for the current year.

In other Aceto news, Chairman Albert L. Eilender sold 9,530 shares of the stock in a transaction on Wednesday, September 6th. The stock was sold at an average price of $10.47, for a total value of $99,779.10. Following the sale, the chairman now owns 307,028 shares in the company, valued at $3,214,583.16. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Salvatore J. Sr Guccione, Sr. sold 9,850 shares of the stock in a transaction on Wednesday, September 6th. The stock was sold at an average price of $10.47, for a total value of $103,129.50. Following the completion of the sale, the insider now owns 241,262 shares in the company, valued at approximately $2,526,013.14. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 26,283 shares of company stock valued at $275,189. 4.10% of the stock is owned by corporate insiders.

ACET has been the subject of a number of research reports. Canaccord Genuity reiterated a “buy” rating and set a $15.00 target price (down from $19.00) on shares of Aceto in a research report on Monday, August 28th. ValuEngine upgraded Aceto from a “hold” rating to a “buy” rating in a research report on Wednesday, September 13th. Finally, Zacks Investment Research upgraded Aceto from a “strong sell” rating to a “hold” rating in a research report on Monday, October 30th. One analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $15.00.

ILLEGAL ACTIVITY WARNING: This piece was reported by Watch List News and is owned by of Watch List News. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.watchlistnews.com/aceto-corporation-acet-shares-bought-by-parametric-portfolio-associates-llc/1726744.html.

Aceto Profile

Aceto Corporation (Aceto) is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products.

Want to see what other hedge funds are holding ACET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aceto Corporation (NASDAQ:ACET).

Institutional Ownership by Quarter for Aceto (NASDAQ:ACET)

Receive News & Ratings for Aceto Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aceto Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.